NIEHS_DNA_Sequencing_Technical_Evaluation_Criteria_2026.docx
DOCX document 21 KB Posted
- Attached to
- DNA Sequencing Service
- Solicitation number
- 75N98027Q00090
About this file
This is a Technical Evaluation Criteria document for a DNA Sequencing Services solicitation issued by the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS). The evaluation criteria establish the framework for assessing contractor proposals on five primary factors, ranked in descending order of importance: Technical Approach and Sequencing Capability, Personnel Qualifications and Technical Support, Quality Assurance and Quality Control, Facilities and Equipment, and Past Performance.
The technical approach evaluation requires offerors to demonstrate capability in Sanger DNA sequencing using high-throughput automated instrumentation, whole-plasmid sequencing with assembly methodology, and technical support services including primer design and assay optimization. Offerors must show capacity to process approximately 2,000 to 3,000 samples monthly with appropriate sample handling, tracking, and turnaround time management. Personnel qualifications assessment requires identification of key technical and management staff with expertise in high-throughput sequencing, molecular biology, quality control, and data management. Quality assurance evaluation focuses on sequencing quality-control procedures, failure identification and documentation, repeat sequencing protocols, and data integrity protection. Facilities evaluation requires demonstration of sufficient instrumentation capacity, contingency capabilities for equipment failures, electronic tracking systems, and a web-based ordering platform with secure data delivery. Past performance evaluation requires at least two references for recent and relevant DNA sequencing or laboratory service contracts of similar scope, complexity, and volume, with contact information for reference verification. The evaluation emphasizes that technical capability and past performance are more important than price, and the Government intends to award to the responsible offeror whose proposal represents best value.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Combined_syn_sol PCA-NIEHS-00080.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Technical Evaluation Criteria - DNA Sequencing Services
The Government intends to award a contract to the responsible Offeror whose proposal, conforming to the solicitation, represents the best value to the Government, price and other factors considered.
Technical capability and past performance, when combined, are more important than price. The Government will evaluate the Offeror's technical proposal based on the factors below. Technical proposals shall provide sufficient information to demonstrate the Offeror's understanding of and ability to meet the requirements of the Statement of Work (SOW).
The technical evaluation factors are listed in descending order of importance.
Factor 1 - Technical Approach and Sequencing Capability
The Offeror shall describe its technical approach and demonstrate its capability to provide the DNA sequencing and associated services required by the SOW.
The proposal shall address, at a minimum:
A. Sanger DNA Sequencing
· Capability to perform high-throughput Sanger DNA sequencing using appropriate automated instrumentation, laboratory processes, sample tracking, and quality-control procedures.
· Capability to process the sample types specified in the SOW, including plasmid DNA, genomic DNA, PCR-generated material, and other applicable sample types.
· Capability to perform PCR amplification, PCR product purification, DNA normalization, and modified sequencing procedures when required.
· Ability to provide sequencing data meeting the quality requirements specified in the SOW.
· Procedures for identifying sequencing failures and repeating samples when failures are attributable to Contractor instrumentation, sequencing reactions, or other Contractor technical problems.
B. Whole-Plasmid Sequencing The Offeror shall describe its proposed sequencing and assembly approach for high-throughput whole-plasmid sequencing and demonstrate its ability to generate complete and reliable consensus plasmid sequences.
The proposal shall describe:
· Sequencing and assembly methodology.
· Sequencing and assembly quality-control procedures.
· Procedures for evaluating the quality and completeness of consensus plasmid sequences.
· Capability to provide the whole-plasmid sequencing deliverables specified in the SOW, including raw FASTQ data, sequencing quality-control information, consensus plasmid assemblies, and annotation files.
C. Technical and Assay Support The Offeror shall demonstrate its capability to provide technical support required under the SOW, including, as applicable:
· Primer design.
· Assay development and optimization.
· PCR optimization.
· Sequencing-reaction optimization.
· Troubleshooting of sequencing, template, primer, and assay-related issues.
D. Capacity, Turnaround, and Sample Handling The Offeror shall demonstrate sufficient operational capacity to accommodate an anticipated average workload of approximately 2,000 to 3,000 samples per month and reasonable fluctuations in sample volume.
The proposal shall describe the Offeror's approach to:
· Meeting the turnaround-time requirements specified in the SOW.
· Receiving, identifying, tracking, preserving, and storing samples.
· Maintaining sample traceability throughout processing.
· Transporting samples between the NIEHS campus and the Contractor's facility.
· Notifying Government users of sample receipt and significant sample or sequencing issues.
Factor 2 - Personnel Qualifications and Technical Support The Offeror shall demonstrate that it has qualified personnel with the education, training, experience, and technical expertise necessary to fulfill the requirements of the SOW.
The proposal shall identify key technical and management personnel and describe their relevant experience in areas including:
· High-throughput Sanger DNA sequencing.
· Whole-plasmid sequencing.
· Molecular biology and PCR.
· Primer design and assay optimization.
· Sequencing quality control and troubleshooting.
· Laboratory operations and sample tracking.
· Sequencing data management and delivery.
The Offeror shall demonstrate that sufficient qualified personnel will be available throughout the period of performance to support anticipated sequencing volumes and required turnaround times.
If subcontractors are proposed for a material portion of the technical work, the Offeror shall describe the subcontractor's qualifications, responsibilities, and the Offeror's approach for managing the subcontractor to prevent adverse effects on quality, turnaround time, communication, or other contract requirements.
Factor 3 - Quality Assurance and Quality Control The Offeror shall describe its quality-assurance and quality-control approach for providing reliable and reproducible DNA sequencing services.
The proposal shall address, at a minimum:
· Sequencing quality-control procedures and acceptance criteria.
· Procedures for identifying and documenting unsuccessful sequencing results.
· Procedures for determining whether failures are attributable to Contractor performance, sample quality, template generation, primers, or other causes.
· Procedures for repeat sequencing and corrective action.
· Whole-plasmid sequencing and assembly quality control.
· Sample identification, tracking, and traceability.
· Protection, backup, and integrity of sequencing data.
· Procedures for identifying and resolving significant performance or quality issues.
Factor 4 - Facilities, Equipment, Ordering, and Data Management The Offeror shall describe the facilities, instrumentation, laboratory systems, and operational resources that will be available to perform the SOW.
The proposal shall demonstrate:
· Sufficient sequencing instrumentation and laboratory capacity to support anticipated workload and turnaround requirements.
· Appropriate contingency or operational capability to minimize disruption resulting from equipment or system failures.
· Electronic sample identification and tracking capability.
· A web-based ordering system supporting sequencing requests, sample information, order tracking, communication, and retrieval of sequencing results.
· Capability to generate the electronic sequencing deliverables and file formats required by the SOW.
· Appropriate protection, backup, and secure delivery of sequencing data and associated contract information.
Factor 5 - Past Performance The Offeror shall provide at least two (2) references for recent and relevant contracts, agreements, or commercial customers involving DNA sequencing or laboratory services similar in scope, complexity, volume, and turnaround requirements to this acquisition.
For each reference, the Offeror shall provide:
· Name of the organization.
· Contract, agreement, or project description.
· Description of the Offeror's responsibilities and their relevance to this requirement.
· Period of performance.
· Point-of-contact name, title, telephone number, and email address.
Past performance will be evaluated for relevance and quality of performance. The Government may consider information provided by the Offeror as well as other relevant past-performance information available to the Government.
An Offeror without a record of relevant past performance, or for whom relevant past performance information is not available, will not be evaluated favorably or unfavorably solely on that basis.
File details come from the government source that posted it. Updated .